Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Cosimo Commisso

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7884-9210; OpenAlex author ID A5080326390; NIH RePORTER profile ID 10376567. Sources: funder_awards.

Their work

Papers
13 (first author 1, last author 6)
Trials
0
Grants
9
Labs led
1
Collaborators
41
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: none · 2015: 1 paper, 1 grant · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 4 papers · 2021: 1 grant · 2022: none · 2023: none · 2024: 2 papers · 2025: 4 papers, 3 grants · 2026: 2 papers, 3 grants

Papers 13

  1. The Aging Microenvironment Is a Determinant of Immune Exclusion and Metastatic Fate in Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-25-1904↗
  2. Tumor-derived SAA1-TLR4 signaling drives tumor-to-muscle communication in pancreatic cancer cachexia Co-author DOI 10.64898/2026.09.04.748998↗
  3. Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer. Last author DOI 10.1016/j.ccell.2025.06.021↗
  4. PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2025.116199↗
  5. Disabling PSGL-1 abrogates immune suppression and resistance to PD-1 blockade in pancreatic cancer Co-author DOI 10.1101/2025.05.22.655365↗
  6. MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/0008-5472.can-24-0744↗
  7. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s43018-023-00649-1↗
  8. Macropinocytosis controls metabolic stress-driven CAF subtype identity in pancreatic cancer Last author DOI 10.1101/2024.11.29.625709↗
  9. Metabolic regulation of EGFR effector and feedback signaling in pancreatic cancer cells requires K-Ras. First author DOI 10.1016/j.bbrc.2020.09.029↗
  10. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Co-author DOI 10.1053/j.gastro.2020.07.046↗
  11. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer. Last author DOI 10.1084/jem.20200388↗
  12. Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells. Last author DOI 10.1158/2159-8290.cd-19-1007↗
  13. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Co-author DOI 10.1158/0008-5472.can-14-2211↗

Grants 9

  1. Macropinocytosis: A Paradigm Shift from Metabolic Inhibition to Lethal Hyper-Activation in PDAC AWARD lustgarten:2026-cosimo-commisso-phd-macropinocytosis-a-paradigm-shift-from-m
  2. Macropinocytosis Inhibition as a Glutamine Mimetic Sensitization Strategy in Pancreatic Cancer R01CA272433↗
  3. Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer R01CA276193↗
  4. Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma R01CA207189↗
  5. Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma R01CA254806↗
  6. The Aging Pancreas as a Pro-tumorigenic Niche R21AG087544↗
  7. The Macropinosome: Uncovering the Molecular Anatomy of an Oncogene-driven Organelle R21CA243701↗
  8. Targeting macropinocytosis via Na+/H+ exchanger inhibition in PDAC AWARD pancan:2015-cosimo-commisso-phd-targeting-macropinocytosis-via-na-h-exch
  9. Pancreatic Cancer, Macropinocytosis and Nutrient Internalization AWARD pancan:2011-cosimo-commisso-phd-pancreatic-cancer-macropinocytosis-and-n

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yijuan Zhang · 8 shared papers, 2020–2026 · strength 1.50
  2. Susanne Heynen-Genel · 1 shared grant, 2026 · strength 1.26
  3. Cheska Marie Galapate · 5 shared papers, 2024–2026 · strength 1.07
  4. Andrew M. Lowy · 5 shared papers, 2020–2025 · strength 0.86
  5. Linda M. Bradley · 3 shared papers, 2024–2025 · strength 0.60
  6. Jennifer L. Hope · 3 shared papers, 2024–2025 · strength 0.60
  7. Anindya Bagchi · 4 shared papers, 2020–2025 · strength 0.59
  8. Maria Victoria Recouvreux · 3 shared papers, 2020–2024 · strength 0.41
  9. Yoav Altman · 2 shared papers, 2025 · strength 0.40
  10. Ling Li · 2 shared papers, 2025 · strength 0.40
  11. Hervé Tiriac · 2 shared papers, 2024–2025 · strength 0.35
  12. Priyanka Gupta · 1 shared paper, 2026 · strength 0.29
  13. Szu-Wei Lee · 1 shared paper, 2020 · strength 0.24
  14. Koen M.O. Galenkamp · 2 shared papers, 2020 · strength 0.23
  15. Gabriele Guarnaccia · 1 shared paper, 2026 · strength 0.21
  16. Alessandra Sacco · 1 shared paper, 2026 · strength 0.21
  17. Chantal Pauli · 1 shared paper, 2025 · strength 0.20
  18. Brooke M. Emerling · 1 shared paper, 2025 · strength 0.20
  19. Gurpreet K. Arora · 1 shared paper, 2025 · strength 0.20
  20. Katelyn T. Byrne · 1 shared paper, 2025 · strength 0.20
  21. Divya Sood · 1 shared paper, 2025 · strength 0.17
  22. Bharti Garg · 1 shared paper, 2025 · strength 0.17
  23. Nirakar Rajbhandari · 1 shared paper, 2025 · strength 0.17
  24. Pnina Brodt · 1 shared paper, 2025 · strength 0.17
  25. Kevin Christian Montecillo Gulay · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.